電視廣播(00511.HK)遭基金股東Dodge&Cox再減持 小股東聯盟預告明日公布改革方案
電視廣播(00511.HK)基金股東Dodge&Cox連日再度減持,繼3月9日沽貨套現7,838萬元後,聯交所權益披露資料顯示,Dodge&Cox於3月10日以平均價每股11.1812元,出售391.33萬股電視廣播股份,涉資約4,375.53萬元。
完成減持後,Dodge&Cox於電視廣播的持股由8.08%進一步降至7.19%。連續兩日Dodge&Cox合共減持電視廣播991.94萬股,套現約1.2億元。
由電視廣播部分小股東所組成的「大台小股東大聯盟」則預告,將於本周五(17日)公布為拯救公司而策劃的「改革TVB方案」,目標是令電視廣播盡快扭虧為盈。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.